Stephen Dubner spent half a century believing a childhood rash meant penicillin allergy. Allergist Kimberly Blumenthal’s research shows his experience is common: viral infections cause rashes, and coincidental antibiotic prescriptions create a lifelong misdiagnosis. This "broken telephone" effect leaves one in ten Americans with a false label on their chart.
"Viral infections frequently cause rashes in children. When a doctor prescribes an antibiotic at the same time, the parent and physician often misattribute the rash to the drug."
- Kimberly Blumenthal, Freakonomics Radio
The label isn’t harmless. Blumenthal’s study of 60,000 patients found it leads to a 14% increase in all-cause mortality. When penicillin is ruled out, doctors resort to broad-spectrum "mallet" drugs like Vancomycin or Clindamycin, which are more toxic, less effective, and drive up rates of C. diff infections and antibiotic resistance.
Delabeling requires a skin prick test or oral challenge, but the system isn’t built for it. There are only 5,000 allergists nationwide. Funding is scarce; Blumenthal was the first researcher to receive an NIH grant for penicillin allergy in 30 years. Medical anthropologist Theresa McPhail notes a $40 billion market for allergy remediation like EpiPens, but basic delabeling science languishes.
"We are excellent at selling EpiPens and antihistamines, but poor at the basic science required to clear patients of false labels."
- Theresa McPhail, Freakonomics Radio
Diagnostics remain stuck in the 19th century. Professor Thomas Platts-Mills argues allergists sit at the bottom of the medical pecking order, unable to secure the large grants that flow to fields like oncology. Without a shift in how wellness visits are reimbursed, the 30 million false labels - and their lethal consequences - will persist indefinitely.
